Li, X., Huang, H., Xu, B., Guo, H., Lin, Y., Ye, S., Yi, J., Li, W., Wu, X., Wang, W., Zhan, H., Xie, D., Peng, J., Cao, Y., Pu, X., Guo, C., Hong, H., Wang, Z., Fang, X., Zhou, Y., and Lin, T. “Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial,” Cancer research and treatment, 51(3), 919-932. October 2018.
has been cited by the following article:
1Department of Internal Medicine, St. Joseph Mercy Oakland Hospital, Michigan, USA
2Ross University School of Medicine, Florida, USA
American Journal of Medical Case Reports.
2022,
Vol. 10 No. 8, 207-209
DOI: 10.12691/ajmcr-10-8-8
Copyright © 2022 Science and Education PublishingCite this paper: Yaqub Nadeem Mohammed, Folake Ishola, Geetha Krishnamoorthy. Unusual Presentation of Primary Extra Nodal Diffuse Large B Cell Lymphoma.
American Journal of Medical Case Reports. 2022; 10(8):207-209. doi: 10.12691/ajmcr-10-8-8.
Correspondence to: Geetha Krishnamoorthy, Department of Internal Medicine, St. Joseph Mercy Oakland Hospital, Michigan, USA. Email:
geetha.krishnamoorthy@trinity-health.orgAbstract
Diffuse Large B Cell Lymphoma (DLBCL) is the most frequently occurring type of Non-Hodgkin Lymphoma (NHL). Primary extra nodal Diffuse Large B Cell Lymphoma (PE-DLBCL) originating in the bone, specifically the thoracic spine, is rare. We describe the case of a 69-year-old male who presented to our facility with back pain and acute bilateral lower extremity paraplegia as Primary extra nodal Diffuse Large B Cell Lymphoma.
Keywords